Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sperginn is a line of dietary supplements developed by INNventa Pharm specifically formulated to support male reproductive health. The product line includes Sperginn Forte and Sperginn Q10, which contain a synergistic blend of amino acids (such as L-arginine, L-carnitine, L-ornithine, and L-citrulline), antioxidants (vitamin C, vitamin E, and coenzyme Q10), and minerals like zinc. These supplements are designed to improve sperm count, motility, and quality, while also supporting normal testosterone levels and addressing symptoms of erectile dysfunction. L-arginine serves as a precursor for nitric oxide production, which is essential for healthy blood flow and erectile function, while the antioxidant components protect sperm cells from oxidative stress and zinc contributes to normal fertility and reproduction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sperginn.